How effective is Abilify for Attention Deficit Hyperactivity Disorder? (a real world drug study)
Summary:
Overall ratings: 2.9/5 Long term ratings: 3.1/5
This is a phase IV clinical study of how effective Abilify (aripiprazole) is for Attention deficit hyperactivity disorder and for what kind of people. The study is created by eHealthMe from 22 Abilify users and is updated continuously.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,449 Abilify users. Check the latest studies of Abilify.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 630 drugs and 1,389 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.
22 people are studied for taking Abilify in Attention deficit hyperactivity disorder
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Abilify effectiveness for Attention deficit hyperactivity disorder (number of people):
Overall:
- not at all: 3
- somewhat: 6
- moderate: 5
- high: 7
- very high: 1
Long Term:
- not at all: 2
- somewhat: 1
- moderate: 1
- high: 6
- very high: 0
Gender of people who take Abilify for Attention deficit hyperactivity disorder *:
- female: 31.82 %
- male: 68.18 %
Age of people who take Abilify for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 27.27 %
- 10-19: 45.45 %
- 20-29: 9.09 %
- 30-39: 9.09 %
- 40-49: 9.09 %
- 50-59: 0.0 %
- 60+: 0.0 %
Who find Abilify more effective for Attention Deficit Hyperactivity Disorder?
Gender of people who take Abilify for Attention deficit hyperactivity disorder *:
- female: 37.5 %
- male: 62.5 %
Age of people who take Abilify for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 12.5 %
- 10-19: 62.5 %
- 20-29: 12.5 %
- 30-39: 0.0 %
- 40-49: 12.5 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Abilify?
- You can start a phase IV clinical trial to monitor Abilify safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Abilify (101,449 reports)
Treatments, associated drugs and conditions:
- Attention deficit hyperactivity disorder (120,306 reports)
How the study uses the data?
The study is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Methotrexate Sodium and Joint Pain for Men aged 40-49 - 7 seconds ago
- Methotrexate Sodium and Bone And Joint Pain for Men aged 40-49 - 7 seconds ago
- Methotrexate Sodium and Joint Aches for Men aged 40-49 - 8 seconds ago
- Methotrexate Sodium and Stiffness In A Joint for Men aged 40-49 - 8 seconds ago
- Methotrexate Sodium and Arthralgia for Men aged 40-49 - 8 seconds ago
- Methotrexate Sodium and Pain - Joints for Men aged 40-49 - 9 seconds ago
- Lisinopril and Cardiac Murmur for Men aged 60+ - 36 seconds ago
- Could Coreg cause Dry Throat? - 37 seconds ago
- Synthroid and Panic Attack for Men aged 60+ - 44 seconds ago
- Synthroid and Panic Attacks for Men aged 60+ - 44 seconds ago